shutterstock_1905552877_nitpicker

nitpicker / Shutterstock.com

4 November 2021GenericsAlex Baldwin

EPO upholds Bayer's Xarelto dosage patents

Following two-day oral proceedings at the Munich Board of Appeal of the European Patent Office (EPO), the court has upheld the validity of a Bayer Pharmaceuticals’ dosing patent for Xarelto (rivaroxaban).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Bayer and Boston hospitals collaborate on COPD lab

26 September 2019 Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Bayer and CRISPR close joint venture transaction

19 August 2016 Bayer has launched a partnership with CRISPR Therapeutics.

Biotechnology

Cohausz & Florack hires senior technical duo

19 January 2023 Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.

More on this story

Bayer and Boston hospitals collaborate on COPD lab

26 September 2019 Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Bayer and CRISPR close joint venture transaction

19 August 2016 Bayer has launched a partnership with CRISPR Therapeutics.

Biotechnology

Cohausz & Florack hires senior technical duo

19 January 2023 Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.

More on this story

Bayer and Boston hospitals collaborate on COPD lab

26 September 2019 Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Bayer and CRISPR close joint venture transaction

19 August 2016 Bayer has launched a partnership with CRISPR Therapeutics.

Biotechnology

Cohausz & Florack hires senior technical duo

19 January 2023 Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent